Mikiko Ohno Selected Research

Metalloendopeptidases (Metalloendopeptidase)

1/2019	Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.
1/2018	Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.
9/2017	Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikiko Ohno Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 05/2012
5	Atherosclerosis 01/2021 - 01/2016
4	Transient Ischemic Attack 01/2021 - 01/2018
4	Diabetes Mellitus 01/2021 - 01/2016
4	Acute Coronary Syndrome 08/2020 - 09/2017
3	Cerebral Infarction 02/2018 - 01/2016
3	Necrosis 09/2017 - 05/2012
2	Ischemic Stroke 01/2021 - 12/2020
2	Chronic Renal Insufficiency 01/2021 - 10/2020
2	Myocardial Infarction 01/2021 - 09/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 10/2020
2	Esophageal Squamous Cell Carcinoma 12/2020 - 10/2020
2	Amyloid Plaque 01/2014 - 09/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 09/2007
1	Hypotension (Low Blood Pressure) 01/2020
1	Bradycardia 01/2020
1	Inflammation (Inflammations) 01/2019
1	Cholangiocarcinoma 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2018
1	Carcinogenesis 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2017
1	Unstable Angina 09/2017
1	Hepatitis C 05/2017
1	Hepatocellular Carcinoma (Hepatoma) 05/2017
1	Arthritis (Polyarthritis) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 10/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Stomach Neoplasms (Stomach Cancer) 05/2012

Drug/Important Bio-Agent (IBA)

11	nardilysinIBA 01/2021 - 05/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2007
6	Biomarkers (Surrogate Marker)IBA 12/2020 - 09/2017
4	Peptides (Polypeptides)IBA 01/2021 - 09/2007
4	AntigensIBA 01/2021 - 09/2017
3	AntibodiesIBA 01/2021 - 01/2018
3	Complementary DNA (cDNA)IBA 01/2021 - 10/2020
3	Metalloendopeptidases (Metalloendopeptidase)IBA 01/2019 - 09/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2016
2	Immunoglobulin G (IgG)IBA 01/2021 - 10/2020
2	ImmunosorbentsIBA 01/2021 - 10/2020
2	AutoantibodiesIBA 02/2018 - 09/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2014 - 09/2007
2	Amyloid beta-PeptidesIBA 01/2014 - 09/2007
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2014 - 09/2007
1	Recombinant ProteinsIBA 01/2021
1	Gemcitabine FDA Link 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2017
1	CollagenIBA 01/2017
1	AdiponectinIBA 01/2016
1	InterleukinsIBA 05/2012
1	Peptide Hydrolases (Proteases)FDA Link 05/2012
1	CytokinesIBA 05/2012

Therapy/Procedure

1	Hepatectomy 05/2017